This risk may be compounded by concomitant medications such as diuretics or SGLT2 inhibitors
Feeling cold while taking GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound)the latter being a dual GIP/GLP-1 receptor agonistis something many patients report anecdotally, though it is not listed as an official adverse effect in FDA-approved labeling for these medications
He explains that while Ozempics primary action is to stimulate insulin secretion and lower glucagon secretion, it also has a secondary effect of slowing digestion
Additionally, it slows down the emptying of the stomach and reduces appetite, allowing for more effective nutrition absorption
Specific situations requiring medical assessment include: Rapid onset: Hair loss beginning within the first month of treatment, before significant weight loss has occurred, may suggest an alternative cause